SCHEMBL4507101

SCHEMBL4507101

COC(=O)c1cnn2c(Cl)c(-c3c(F)cccc3Cl)c(Cl)nc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.46
ALDH1A1 P00352 8/20 0.46
HPGD P15428 6/20 0.46
HSD17B10 Q99714 6/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
TP53 P04637 5/20 0.44
CASP1 P29466 2/20 0.42
TSHR P16473 2/20 0.42
HTR2C P28335 1/20 0.41
LMNA P02545 2/20 0.41
KMT2A Q03164 2/20 0.40
GAA P10253 2/20 0.40
MEN1 O00255 1/20 0.40
ESR1 P03372 1/20 0.40
POLB P06746 1/20 0.40
CASP7 P55210 1/20 0.40
ESR2 Q92731 1/20 0.40
NPC1 O15118 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3713237 0.94 KDM4E (0.48) KDM4EALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL13606405 0.90 KDM4E (0.46) KDM4EALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL4494543 0.84 KDM4E (0.41) KDM4EALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL4512702 0.84 KDM4E (0.43) KDM4EALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL3716845 0.80 ALDH1A1 (0.48) KDM4EALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL3536274 0.77 DPP4 (0.44) KDM4EALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL3706568 0.76 AKT1 (0.50) KDM4EALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL13232459 0.75 KDM4E (0.52) KDM4EALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL2792352 0.75 MAPT (0.42) KDM4EALDH1A1HPGDHSD17B10L3MBTL1
SCHEMBL25117818 0.74 KDM4E (0.50) KDM4EALDH1A1HPGDHSD17B10L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629294-B2 Pyrazolopyrimidines BAYER CROPSCIENCE LP (DE) 2009-12-08 US disclosed
US-7629294-B2 Pyrazolopyrimidines BAYER CROPSCIENCE LP (DE) 2009-12-08 US disclosed
US-7629294-B2 Pyrazolopyrimidines BAYER CROPSCIENCE LP (DE) 2009-12-08 US disclosed
EP-1718652-A2 PYRAZOLOPYRIMIDINES FOR COMBATTING UNWANTED MICROORGANISMS Bayer CropScience Aktiengesellschaft (DE) 2006-11-08 EP disclosed
WO-2005082907-A2 PYRAZOLOPYRIMIDINES FOR CONTROLLING UNDESIRED MICROORGANISMS BAYER CROPSCIENCE AG (DE) 2005-09-09 WO disclosed
US-20050187224-A1 Pyrazolopyrimidines BAYER CROPSCIENCE AG (DE) 2005-08-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187224-A1 Pyrazolopyrimidines P2RX5, P2RX4, P2RX1 KDM4E 2400/4885ALDH1A1 535/4885HPGD 1756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.